Sinil Pharmaceutical Co Ltd
KOSDAQ:012790
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sinil Pharmaceutical Co Ltd
Gross Profit
Sinil Pharmaceutical Co Ltd
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sinil Pharmaceutical Co Ltd
KOSDAQ:012790
|
Gross Profit
₩36.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
|
Yuhan Corp
KRX:000100
|
Gross Profit
₩729.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Gross Profit
₩663.8B
|
CAGR 3-Years
47%
|
CAGR 5-Years
94%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Gross Profit
₩884.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
0%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Gross Profit
₩109.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Gross Profit
₩52.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Sinil Pharmaceutical Co Ltd
Glance View
Sinil Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Chungju, Chungcheongbuk-Do. The Company’s products consist of antihyperlipidemic agents, antitussives, expectorants, anti-antipyretic agents, analgesic agents, inflammatory agents, dermatological treatments, chemotherapeutic agents, antihistamines, antihypertensives and mixed vitamins, among others. The company also engages in the leasing of real estate.
See Also
What is Sinil Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
36.5B
KRW
Based on the financial report for Sep 30, 2025, Sinil Pharmaceutical Co Ltd's Gross Profit amounts to 36.5B KRW.
What is Sinil Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
5%
Over the last year, the Gross Profit growth was -9%. The average annual Gross Profit growth rates for Sinil Pharmaceutical Co Ltd have been 4% over the past three years , 6% over the past five years , and 5% over the past ten years .
